Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer (Q37398007)

20 August 2017

Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer (English)

1 reference

20 August 2017

1 reference

cervix uterine cancer

1 reference

14

Mark Schiffman

1 reference

20 August 2017

13

Sholom Wacholder

1 reference

20 August 2017

3

Robert D Burk

1 reference

20 August 2017

Ana Cecilia Rodríguez

series ordinal

2

object named as

Ana C Rodríguez

1 reference

20 August 2017

4

Rolando Herrero

1 reference

20 August 2017

7

Mark E Sherman

1 reference

20 August 2017

1

Philip E Castle

1 reference

20 August 2017

12

Martha L Hutchinson

1 reference

20 August 2017

11

Diego Guillén

1 reference

20 August 2017

5

Allan Hildesheim

1 reference

20 August 2017

6

Diane Solomon

1 reference

20 August 2017

Jose Jeronimo

8

1 reference

20 August 2017

Mario Alfaro

series ordinal

9

1 reference

20 August 2017

Jorge Morales

series ordinal

10

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

International Journal of Cancer

20 August 2017

1 reference

20 August 2017

125

1 reference

20 August 2017

7

1 reference

20 August 2017

1649-1656

1 reference

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Chapter 7: Achievements and limitations of cervical cytology screening

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Prospective randomized trial of LLETZ versus laser ablation in patients with cervical intraepithelial neoplasia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Audit of deaths from cervical cancer: proposal for an essential component of the National Screening Programme

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Number of cervical biopsies and sensitivity of colposcopy.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Colposcopy at a crossroads.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

The carcinogenicity of human papillomavirus types reflects viral evolution.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Interlaboratory reliability of Hybrid Capture 2.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries

3 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766540

Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica

3 December 2018

1 reference

12 December 2020

Cervical Cancer in Women With Comprehensive Health Care Access: Attributable Factors in the Screening Process

1 reference

12 December 2020

Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program

1 reference

12 December 2020

Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting

1 reference

12 December 2020

Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002

1 reference

12 December 2020

Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence

1 reference

12 December 2020

Inflation of Sensitivity of Cervical Cancer Screening Tests Secondary to Correlated Error in Colposcopy

1 reference

12 December 2020

Human papillomavirus and cervical cancer

1 reference

12 December 2020

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

1 reference

12 December 2020

Heterogeneity in CIN3 diagnosis

1 reference

12 December 2020

Routine audit of large-scale cervical cancer screening programs

1 reference

12 December 2020

Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica

1 reference

12 December 2020

Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project

1 reference

12 December 2020

An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV)

1 reference

12 December 2020

Comparisons of HPV DNA detection by MY09/11 PCR methods

1 reference

12 December 2020

Adenocarcinoma in situ of the cervix: sensitivity of detection by cervical smear: will cytologic screening for adenocarcinoma in situ reduce incidence rates for adenocarcinoma

1 reference

12 December 2020

A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer

1 reference

12 December 2020

Identifiers

DOI

10.1002/IJC.24525

1 reference

release_z42hq4zozbhihluvyrxrf27kfm

20 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z42hq4zozbhihluvyrxrf27kfm

24 November 2022

mapped directly with Wikidata item

1 reference

20 August 2017

1 reference